Vivesto
0,263
SEK
-1,32 %
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
2 investorer følger denne virksomhed
-1,32%
-0,19%
+1,35%
-13,65%
-35,58%
+39,78%
-87,45%
-93,6%
-98,55%
www.vivesto.com/en
Vivesto is a research company. The company specializes in the research and development of drugs for serious diseases in oncology. The technology is based on the company's technical platform where research is based on nanotechnology. Today, operations are conducted mainly in the Nordic countries and North America. The company was founded in 1999 and has its headquarters in Uppsala.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
VIVE
Daglig lav / høj pris
0,26 / 0,27
SEK
Markedsværdi
141,24 mio. SEK
Aktieomsætning
54,69 t SEK
Volumen
207 t
Seneste videoer
Finanskalender
Årsrapport
20.02.2025
Større aktionærerKilde: Millistream Market Data AB
| Ejer | Kapital | Stemmer |
|---|---|---|
| Per Arwidsson med bolag | 24,8 % | 24,8 % |
| Avanza Pension | 5,7 % | 5,7 % |
| Swedbank Försäkring | 1,5 % | 1,5 % |
| Johan Zetterstedt | 1,5 % | 1,5 % |
| Nordnet Pensionsförsäkring AB | 1,1 % | 1,1 % |
| Mastan AB (Håkan Lagerberg) | 1,0 % | 1,0 % |
| Philip Du Rietz | 0,9 % | 0,9 % |
| Jerry Wiström | 0,9 % | 0,9 % |
| Christer Ericson | 0,7 % | 0,7 % |
| Handelsbanken Liv Försäkring AB | 0,7 % | 0,7 % |
ViserAlle indholdstyper
Vivesto signs Apealea option agreement with Zhida Pharmaceutical
Vivesto receives positive Cantrixil preclinical efficacy data
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools